Literature DB >> 2892221

Antihistaminics enhance morphine-, but not amphetamine- and scopolamine-induced hyperactivity in mice.

M Sansone1, B D'Udine, P Renzi, J Vetulani.   

Abstract

Three histamine H1-receptor antagonists, chlorpheniramine, diphenhydramine and tripelennamine, were tested alone or in combination with morphine, amphetamine and scopolamine on locomotor activity in mice. All three antihistaminics, at some dosage levels, enhanced morphine-induced hyperactivity, but did not change or even reduce locomotor stimulation induced by amphetamine and scopolamine. The results suggest that H1-blocking agents may specifically interact, though not necessarily directly, with opiate mechanisms in producing behavioural effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892221     DOI: 10.1007/bf00179926

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Psychobiology of opioids.

Authors:  A Oliverio; C Castellano; S Puglisi-Allegra
Journal:  Int Rev Neurobiol       Date:  1984       Impact factor: 3.230

2.  Enhancement of morphine-induced hyperactivity by antihistaminic drugs in mice.

Authors:  M Sansone; C Castellano; F R D'Amato
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-12

3.  Lethality of pentazocine and tripelennamine combinations in mice housed individually and in groups.

Authors:  A Poling; J Kesselring; R G Sewell; J Cleary
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

4.  Potentiation of lethality in mice by combinations of pentazocine and tripelennamine.

Authors:  D P Waller; N L Katz; R W Morris
Journal:  Clin Toxicol       Date:  1980-03       Impact factor: 4.467

5.  Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.

Authors:  E Tagashira; J F Kachur; W H Carter; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

6.  Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels.

Authors:  H E Shannon; T P Su
Journal:  Pharmacol Biochem Behav       Date:  1982-10       Impact factor: 3.533

7.  Analgesic potentiation and the distribution of morphine in the presence of triplennamine in mice.

Authors:  R E Bluhm; M A Evans; E K Zsigmond
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

8.  Tripelennamine and pentazocine alone and in combination: effects on interresponse-time-greater-than-t responding of rats.

Authors:  D Grossett; S Wallace; M Picker; A Poling
Journal:  Pharmacol Biochem Behav       Date:  1984-05       Impact factor: 3.533

9.  Opposite effects of chlordiazepoxide and serotonin receptor antagonists on morphine-induced locomotor stimulation in mice.

Authors:  M Sansone
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Pentazocine and tripelennamine: a drug abuse epidemic?

Authors:  H W Lahmeyer; R G Steingold
Journal:  Int J Addict       Date:  1980-11
View more
  3 in total

1.  Calcium channel blockers: effect on morphine-induced hypermotility.

Authors:  M I Martin; I Lizasoain; J C Leza
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice.

Authors:  M Sansone; C Castellano; V Libri
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity.

Authors:  M F O'Neill; A G Fernández; R W Gristwood; J M Palacios
Journal:  J Neural Transm Gen Sect       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.